Pharmacosurveillance in Juvenile Idiopathic Arthritis-Reference-Cited by-同舟云学术

Pharmacosurveillance in Juvenile Idiopathic Arthritis

Published:2021-11 Issue:4 Volume:47 Page:643-653
ISSN:0889-857X
Container-title:Rheumatic Disease Clinics of North America
language:en
Short-container-title:Rheumatic Disease Clinics of North America

Author:

Shiff Natalie J.,Beukelman Timothy

Publisher

Elsevier BV

Subject

Rheumatology

Reference42 articles.

1. The development and assessment of biological treatments for children;Smith;Br J Clin Pharmacol,2014

2. 2019 American College of Rheumatology/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis;Ringold;Arthritis Care Res (Hoboken),2019

3. 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among C

4. World Health Organization. Quality Assurance and Safety of Medicines Team. Safety of medicines: a guide to detecting and reporting adverse drug reactions: why health professionals need to take action. Geneva (Switzerland); 2002. Available at: https://apps.who.int/iris/handle/10665/67378. Accessed February 26, 2021.

5. Toward accelerated authorization and access to new medicines for juvenile idiopathic arthritis;Schanberg;Arthritis Rheumatol,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry;RMD Open;2023-05

2. The effect of TNF treatment uptake on incident hospital admission in Western Australia;Pediatric Rheumatology;2023-03-28

3. Insurance Status and Tumor Necrosis Factor Inhibitor Initiation Among Children With Juvenile Idiopathic Arthritis in the CARRA Registry;The Journal of Rheumatology;2022-12-15

4. Safety and efficacy of probiotic supplementation in 8 types of inflammatory arthritis: A systematic review and meta-analysis of 34 randomized controlled trials;Frontiers in Immunology;2022-09-23

5. Implications of Evolving Disease Classification for Drug Approval in Juvenile Idiopathic Arthritis;Pediatric Drugs;2022-04-01